Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease

被引：22
|
作者：
Sarkar, Arighna [1 ]
Mandal, Kalyaneswar [1 ]
机构：
[1] Tata Inst Fundamental Res Hyderabad, TIFR Ctr Interdisciplinary Sci, 36-P Gopanpally, Hyderabad 500046, Telangana, India
来源：
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2021年 / 60卷 / 44期
关键词：
allosteric inhibitors; antiviral drugs; drug screening; SARS-CoV-2; X-ray crystallographic screening;
D O I：
10.1002/anie.202107481
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：23492 / 23494
页数：3
相关论文
共 50 条
  • [21] Venetoclax: a promising repurposed drug against SARS-CoV-2 main protease
    Ghosh, Suvankar
    Bhattacherjee, Debojit
    Satpati, Priyadarshi
    Bhabak, Krishna Pada
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (22): : 12088 - 12099
  • [22] Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
    Isgro, Camilla
    Sardanelli, Anna Maria
    Palese, Luigi Leonardo
    VIRUSES-BASEL, 2021, 13 (01):
  • [23] Repurposing pharmaceutical excipients as an antiviral agent against SARS-CoV-2
    Malani, Manisha
    Salunke, Prerana
    Kulkarni, Shraddha
    Jain, Gaurav K.
    Sheikh, Afsana
    Kesharwani, Prashant
    Nirmal, Jayabalan
    JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2022, 33 (01) : 110 - 136
  • [24] Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
    Mahmud, Shafi
    Biswas, Suvro
    Paul, Gobindo Kumar
    Mita, Mohasana Akter
    Afrose, Shamima
    Hasan, Md Robiul
    Shimu, Mst Sharmin Sultana
    Uddin, Mohammad Abu Raihan
    Uddin, Md Salah
    Zaman, Shahriar
    Kibria, K. M. Kaderi
    Khan, Md Arif
    Bin Emran, Talha
    Abu Saleh, Md
    ARABIAN JOURNAL OF CHEMISTRY, 2021, 14 (09)
  • [25] Probing CAS database as prospective antiviral agents against SARS-CoV-2 main protease
    Zia, Komal
    Khan, Salman Ali
    Ashraf, Sajda
    Nur-e-Alam, Mohammad
    Ahmed, Sarfaraz
    Ul-Haq, Zaheer
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1231
  • [26] Drug Repurposing for the SARS-CoV-2 Papain-Like Protease
    Cho, Chia-Chuan
    Li, Shuhua G.
    Lalonde, Tyler J.
    Yang, Kai S.
    Yu, Ge
    Qiao, Yuchen
    Xu, Shiqing
    Ray Liu, Wenshe
    CHEMMEDCHEM, 2022, 17 (01)
  • [27] Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
    Johansen-Leete, Jason
    Ullrich, Sven
    Fry, Sarah E.
    Frkic, Rebecca
    Bedding, Max J.
    Aggarwal, Anupriya
    Ashhurst, Anneliese S.
    Ekanayake, Kasuni B.
    Mahawaththa, Mithun C.
    Sasi, Vishnu M.
    Luedtke, Stephanie
    Ford, Daniel J.
    O'Donoghue, Anthony J.
    Passioura, Toby
    Larance, Mark
    Otting, Gottfried
    Turville, Stuart
    Jackson, Colin J.
    Nitsche, Christoph
    Payne, Richard J.
    CHEMICAL SCIENCE, 2022, 13 (13) : 3826 - 3836
  • [28] Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease
    Kandeel, Mahmoud
    Kim, Jinsoo
    Fayez, Mahmoud
    Kitade, Yukio
    Kwon, Hyung-Joo
    PEERJ, 2022, 10
  • [29] Targeting two potential sites of SARS-CoV-2 main protease through computational drug repurposing
    Prakash, Archisha
    Borkotoky, Subhomoi
    Dubey, Vikash Kumar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (07): : 3014 - 3024
  • [30] Identification of Potential SARS-CoV-2 Main Protease Inhibitors Using Drug Repurposing and Molecular Modeling
    Andrianov, Alexander M.
    Furs, Konstantin V.
    Gonchar, Anna V.
    Xie, Xiong
    Karpenko, Anna D.
    Laikov, Yan V.
    Varabyeu, Danila A.
    Liu, Hong
    Tuzikov, Alexander V.
    BIOINFORMATICS RESEARCH AND APPLICATIONS, PT I, ISBRA 2024, 2024, 14954 : 439 - 448
12345